Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

about

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

Item

http://www.wikidata.org/entity/Q47634056

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@en

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@nl

type

Item

label

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@en

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@nl

prefLabel

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@en

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@nl

P1476

Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.

@en

P2093

Bao-Zhong Wang

http://www.w3.org/2001/XMLSchema#string

Hui-Min Hu

http://www.w3.org/2001/XMLSchema#string

Jun-Ting Ma

http://www.w3.org/2001/XMLSchema#string

Peng-Fei Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Long Gao

http://www.w3.org/2001/XMLSchema#string

Ying-Zi Chai

http://www.w3.org/2001/XMLSchema#string

Ze-Feng Wang

http://www.w3.org/2001/XMLSchema#string

Zhong-Chang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets

Computational approaches for drug discovery.

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors

ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.

Molecular dynamics in drug design.

Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia.

Revisiting de novo drug design: receptor based pharmacophore screening.

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases.

Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).

P304

567-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.13121

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yan-Ting Wang

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29045039

http://www.w3.org/2001/XMLSchema#string